David P. Kerstein

2021

In 2021, David P. Kerstein earned a total compensation of $1.1M as Chief Medical Officer at Theseus Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$163,330
Option Awards$486,084
Salary$409,667
Total$1,059,081

Kerstein received $486.1K in option awards, accounting for 46% of the total pay in 2021.

Kerstein also received $163.3K in non-equity incentive plan and $409.7K in salary.

Rankings

In 2021, David P. Kerstein's compensation ranked 8,605th out of 12,415 executives tracked by ExecPay. In other words, Kerstein earned more than 30.7% of executives.

ClassificationRankingPercentile
All
8,605
out of 12,415
31st
Division
Manufacturing
3,814
out of 5,505
31st
Major group
Chemicals And Allied Products
1,687
out of 2,375
29th
Industry group
Drugs
1,501
out of 2,096
28th
Industry
Pharmaceutical Preparations
1,119
out of 1,546
28th
Source: SEC filing on April 26, 2023.

Kerstein's colleagues

We found four more compensation records of executives who worked with David P. Kerstein at Theseus Pharmaceuticals in 2021.

2021

Timothy Clackson

Theseus Pharmaceuticals

Chief Executive Officer

2021

Bradford Dahms

Theseus Pharmaceuticals

Chief Financial Officer

2021

William Shakespeare

Theseus Pharmaceuticals

Co-Founder

2021

Iain MA

Theseus Pharmaceuticals

Chief Executive Officer

News

You may also like